University of Strasbourg

Advent Technologies and Safran Power Units Sign MoU to Advance HT-PEM Fuel Cell Technology for the Aerospace Sector

Retrieved on: 
Wednesday, May 31, 2023
Environment, Technology, Other Energy, Engineering, Aerospace, Alternative Energy, Manufacturing, Green Technology, Energy, Hardware, Hydrogen, French National Centre for Scientific Research, Business development, Partnership, Advent International, National Centre for Universities and Business, University, Joint, French Alternative Energies and Atomic Energy Commission, HT, Aviation, ADN, Research, Technology Center, University of Strasbourg, Green, Strategic management, Safran, Fraunhofer Society, Memorandum of understanding, Sustainable energy, Scientific method, Renewable energy, Airline, Advent

Advent Technologies Holdings, Inc. (NASDAQ: ADN) ("Advent" or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology sectors, today signed a Memorandum of Understanding ("MoU") with Safran Power Units, a leader in auxiliary power systems and turbojet engines.

Key Points: 
  • Advent Technologies Holdings, Inc. (NASDAQ: ADN) ("Advent" or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology sectors, today signed a Memorandum of Understanding ("MoU") with Safran Power Units, a leader in auxiliary power systems and turbojet engines.
  • Leveraging Advent's proprietary Ion Pair™ Membrane Electrode Assembly (“MEA”) technology, and Safran Aerospace knowledge and capabilities, this new collaboration will seek to advance the development of next-generation high-temperature proton exchange membrane (“HT-PEM”) fuel cell technology, specifically for the aerospace sector.
  • "We are excited about the collaboration with Safran Power Units, as it signifies a major leap forward in advancing our HT-PEM fuel cell technology for the aerospace sector," commented Dr. Vasilis Gregoriou, Advent’s Chairman and CEO.
  • By combining our strengths, we are confident in our ability to spearhead the advancement of HT-PEM fuel cell technology in the aerospace sector.

ARBONNE ANNOUNCES NEW HR LEADERSHIP APPOINTMENT

Retrieved on: 
Friday, April 21, 2023
Deakin University, Senior, University of Strasbourg, Biotechnology, Human, Certification, Beauty, Growth, Government, Arbonne International, Grenoble Alpes University, Management, UMB, Arbonne

IRVINE, Calif., April 21, 2023 /PRNewswire/ -- Arbonne International, a global leader in personal care, nutrition, beauty, and wellness products, announces that Léa Baltzinger has joined Arbonne as its Chief People Officer. The new appointment complements the company's investment in cultivating culture to meet a dynamic future in direct selling while supporting Arbonne's mission. 

Key Points: 
  • IRVINE, Calif., April 21, 2023 /PRNewswire/ -- Arbonne International , a global leader in personal care, nutrition, beauty, and wellness products, announces that Léa Baltzinger has joined Arbonne as its Chief People Officer.
  • The new appointment complements the company's investment in cultivating culture to meet a dynamic future in direct selling while supporting Arbonne's mission.
  • "Léa brings tremendous global experience in human resources leadership and organizational development to our team," said Tyler Whitehead, CEO of Arbonne.
  • Baltzinger has held senior HR leadership positions in multiple industries, including hospitality, retail, consumer electronics and biotechnology.

U.S. FDA Grants 510(k) Expanded Indication for Palliare’s EVA15 Insufflation Technology to Accommodate Higher Pressure Range

Retrieved on: 
Tuesday, January 31, 2023
Chairperson, PABI, Food, Bariatric surgery, BMI, University of Strasbourg, GERD, Insufflation (medicine), Dissection, Patient, CO2, ESG, Regulation of tobacco by the U.S. Food and Drug Administration, Smoke, Insufflation, Pressure, Endoscopy, University, Medical device

This increased pressure range represents the highest-performing robotic insufflator on the market to offer continuous pressure insufflation, with integrated smoke evacuation, and is designed for surgical, laparoscopic, and robotic surgeries.

Key Points: 
  • This increased pressure range represents the highest-performing robotic insufflator on the market to offer continuous pressure insufflation, with integrated smoke evacuation, and is designed for surgical, laparoscopic, and robotic surgeries.
  • “The company continues to develop a strong intellectual property portfolio, and we are pleased to have recently received U.S. and E.U.
  • EVA15 maintains continuous 7-25mmHg pressure and automatically compensates for leaks and suctioning.
  • The insufflator instantaneously sees a pressure drop and adds extra flow, regardless of why there is flow out of the cavity.

Planet and NASA Harvest Launch Commercial Partnership to Enable and Advance Food Security Offering to Deliver Policy-Grade Agricultural Assessments

Retrieved on: 
Thursday, January 12, 2023
Data Management, Aerospace, Technology, Manufacturing, Food, Beverage, Agriculture, Security, Natural Resources, Satellite, Retail, Food Tech, Classification, Institute for the Study of War, University, Face, Non-governmental organization, Government, NYSE, Partnership, Public sector, Organization, NASA, Climate, Soybean, History of the University of Maryland, College Park, Policy, Food, Igor Sikorsky Kyiv Polytechnic Institute, Research, Map, Food security, CSDA, Multimedia, University of Strasbourg, Agriculture, Renewable energy, Planet

Planet Labs PBC (NYSE: PL), a leading provider of daily data and insights about Earth, and NASA Harvest , the federal space agency’s Global Food Security and Agriculture Program, today announced a partnership to further support the joint Food Security and Agricultural Monitoring Solution.

Key Points: 
  • Planet Labs PBC (NYSE: PL), a leading provider of daily data and insights about Earth, and NASA Harvest , the federal space agency’s Global Food Security and Agriculture Program, today announced a partnership to further support the joint Food Security and Agricultural Monitoring Solution.
  • The offering aims to deliver policy-grade agricultural monitoring and assessments of potential threats to global food security.
  • Replicating that process, and building on existing NASA Harvest expertise in the public sector and Planet’s commercial offerings, the work is now being scaled to conduct regional and global assessments.
  • For more information about accessing the Food Security and Agricultural Monitoring Solution, please email [email protected] .

Contract Law Update Training Course: The Latest Case Law in Practice (January 17, 2023) - ResearchAndMarkets.com

Retrieved on: 
Monday, December 12, 2022
Education, Training, Legal, Professional Services, Technology and Construction Court, University of Strasbourg, European Commission, Court of cassation, IPR, Commercial, Commercial Court, High Court, University, Risk management, European Union law, EU

Helen Swaffield is a practising Barrister with over 25 years' experience in Commercial and Public Law including commercial contracts and regulation, EU Law, international outsourcing and procurement, competition, franchising, supply and distribution and IPR.

Key Points: 
  • Helen Swaffield is a practising Barrister with over 25 years' experience in Commercial and Public Law including commercial contracts and regulation, EU Law, international outsourcing and procurement, competition, franchising, supply and distribution and IPR.
  • Helen appears in the High Court, Commercial Court and Technology and Construction Court as well as commercial arbitrations and adjudications.
  • Helen has a French Law accreditation and has a diploma in EU Law from the University of Strasbourg.
  • Helen has drafted commercial, public and health sector contracts and has developed precedents and templates for industry use.

Contract Law Update Training Course: The Latest Case Law in Practice (January 17, 2023)

Retrieved on: 
Tuesday, October 18, 2022
University of Strasbourg, Technology, European Commission, Court of cassation, Commercial, High Court, University, Industry, Commercial Court, Technology and Construction Court, IPR, Risk management, European Union law, EU

Helen Swaffield is a practising Barrister with over 25 years' experience in Commercial and Public Law including commercial contracts and regulation, EU Law, international outsourcing and procurement, competition, franchising, supply and distribution and IPR.

Key Points: 
  • Helen Swaffield is a practising Barrister with over 25 years' experience in Commercial and Public Law including commercial contracts and regulation, EU Law, international outsourcing and procurement, competition, franchising, supply and distribution and IPR.
  • Helen appears in the High Court, Commercial Court and Technology and Construction Court as well as commercial arbitrations and adjudications.
  • Helen has a French Law accreditation and has a diploma in EU Law from the University of Strasbourg.
  • Helen is the editor of and contributor to the Commercial Litigation Journal and the Procurement and Outsourcing Journal.

Quantum Machines to partner with leading European universities, research institutions and companies on the EuRyQa project

Retrieved on: 
Wednesday, October 12, 2022
Quantum machine learning, Universitate metro station, University, University of Strasbourg, Electronics, Architecture, Technology, Software, SME, Institute of technology, Hotbed, QPU, CEO, University of Stuttgart, TEL, Brain, Running, Quantum, QM, Calibration, Solution, Benchmarking, European Commission, Algorithm, Microscope, Rydberg

TEL AVIV, Israel, Oct. 12, 2022 /PRNewswire/ -- Quantum Machines, the provider of breakthrough quantum control solutions that accelerate the development and implementation of quantum computers, announced today that it will be a partner on the EuRyQa project. The European Commission has just launched the European infrastructure for Rydberg Quantum Computing (EuRyQa) project aimed at establishing Rydberg quantum processors as a leading platform for scalable quantum computing in Europe. Assembling eleven partners from seven countries, EuRyQa is funded under the highly competitive Horizon Europe program (HORIZON-CL4-2021-DIGITAL-EMERGING-01-30) with a total budget of almost €5 million over the next three years.

Key Points: 
  • The European Commission has just launched the European infrastructure for Rydberg Quantum Computing (EuRyQa) project aimed at establishing Rydberg quantum processors as a leading platform for scalable quantum computing in Europe.
  • Quantum Machines (QM) has established itself as the leading provider of control and operation systems the actual "brain" within quantum computers.
  • "The EuRyQa project is an important initiative that will help position Europe as a hotbed of innovation in quantum computing," said Itamar Sivan, co-founder and CEO of Quantum Machines.
  • Quantum Machines (QM) drives quantum breakthroughs that accelerate the path towards the new age of quantum computing.

QunaSys Co-Organizes International Training Workshop on Quantum Computing for Chemistry

Retrieved on: 
Friday, September 30, 2022
University, University of Strasbourg, European Center for Studies and Research in Ethics, Workforce, Agriculture, Algorithm, Electronics, Materials science, CNRS, The Next Revolution, Nobel Prize, View, Investment, EU, Government, Technology, Student, Physics, Ecosystem, Research, Multimedia, ISIS, Biology, Microscope, Medicine, Industry, Chemistry

The workshop will be led by instructors from industry and academia specialized in quantum information, quantum chemistry, experimental and theoretical physics from QunaSys and the Universityof Strasbourg .

Key Points: 
  • The workshop will be led by instructors from industry and academia specialized in quantum information, quantum chemistry, experimental and theoretical physics from QunaSys and the Universityof Strasbourg .
  • The training covers real world examples to help students understand the applicability of quantum computing in the chemistry field.
  • Presented in a modular format, the workshop can be taken as a general overview of quantum computing and its industry applicability, a hands-on coding program to learn quantum computing algorithms and use case development, or as an end-to-end program covering both modules.
  • QunaSys software runs on multiple technology platforms with applicability in all chemical related industries to boost quantum computing adoption.

SATT[1] Conectus and Find Therapeutics Sign Licensing Agreement to Develop a Promising New Therapy for Multiple Sclerosis and other demyelinating diseases

Retrieved on: 
Tuesday, June 7, 2022
People, Multiple Sclerosis Society, Eye, IMS, Program, Research, THE, Institute, Multiple sclerosis, Degenerative disease, Central nervous system, Nerve Damage, Laboratory, AND, Inflammation, CEO, Neuron, Neuroprotection, Disease, Regeneration, Investment, Optic neuritis, Therapy, Patient, MS, ADMAR, Multiple Sclerosis Society of Canada, Immune system, Remyelination, Autoimmune disease, Quality of life, Technology transfer, Inserm, Industry, Drug design, University of Strasbourg, Element, Find, Pharmaceutical industry, Medical device

Promising preclinical data show that this innovative therapy, by overcoming the molecular barriers of myelin regeneration, could restore myelin function.

Key Points: 
  • Promising preclinical data show that this innovative therapy, by overcoming the molecular barriers of myelin regeneration, could restore myelin function.
  • According to the Multiple Sclerosis Society of Canada, Canada has one of the highest MS rates in the world with 1 in every 400 people affected.
  • Initial preclinical pharmacology studies, funded by SATT Conectus, have demonstrated very encouraging results, delivering increased myelin and better function after treatment.
  • Find Therapeutics, is dedicated to the development of next generation trans-membrane allosteric modulators to treat rare and inflammatory diseases.

Captor Therapeutics to Host R&D Day on May 18, 2022

Retrieved on: 
Thursday, May 5, 2022
University of Strasbourg, Drug development, AAP, EDT, University, Laboratory, Gastrointestinal disease, GLOBE, Liver disease, CTX, Cell, Viral, WSE, Cancer, Excellence, ERC, Cell Host & Microbe, Doctor of Philosophy, Funding of science, Hepatocellular carcinoma, Association, American Association, Degenerative disease, Therapy, Computational Biology Department, Patent, Virology, PNAS, Journal, MD, Research and development, R, Institute of Liver and Biliary Sciences, CEST, Center, Infection, HCC, TPD, European Research Council, Editing, American Association of Physician Specialists, Technology, Biology, Chronic liver disease, Pharmaceutical industry, Hepatology, Physician, Gastroenterology, Nature

Furthermore, he is the founder of Alentis Therapeutics, a Swiss/French biotech company developing novel therapeutics for fibrotic diseases and cancer.

Key Points: 
  • Furthermore, he is the founder of Alentis Therapeutics, a Swiss/French biotech company developing novel therapeutics for fibrotic diseases and cancer.
  • Captor Therapeutics is a biopharmaceutical company focused on leveraging Targeted Protein Degradation (TPD) technology to discover and develop breakthrough drug candidates in diseases with high unmet medical needs.
  • Captor is currently developing therapeutics for undertreated severe conditions, including malignancies and autoimmune diseases.
  • More information on Captor Therapeutics is available at: http://www.captortherapeutics.com